Release Date: 26/08/22 09:49 Summary: FY22 Results Media Release Price Sensitive: Yes Download Document 302.44KB Download
TLX Telix gets its foot in the FDA door bringing prostate cancer detection closer to neglected Americans
Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market